Literature DB >> 7911003

Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland.

E M Petty1, J S Green, S J Marx, R T Taggart, N Farid, A E Bale.   

Abstract

An autosomal dominant syndrome of prolactinomas, carcinoids, and hyperparathyroidism was described in four Newfoundland kindreds in 1980 and in one kindred from the Pacific Northwest in 1983. Because this syndrome shares many features with multiple endocrine neoplasia type 1, the gene for which maps to proximal chromosome 11q, we performed linkage studies with chromosome 11 markers in prolactinoma families to determine whether the two genes map to the same location. All proximal chromosome 11q markers gave positive LOD scores, and no recombinants were seen with PYGM (LOD score 15.25, recombination fraction .0). All affected individuals from Newfoundland shared the same PYGM allele, providing evidence for a founder effect. The disease in the Pacific Northwest kindred cosegregated with a different PYGM allele.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911003      PMCID: PMC1918205     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  30 in total

1.  A rapid method for the purification of DNA from blood.

Authors:  M Jeanpierre
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

Review 2.  Genetic aspects of multiple endocrine neoplasia.

Authors:  R N Schimke
Journal:  Annu Rev Med       Date:  1984       Impact factor: 13.739

3.  Prolactinomas in familial multiple endocrine neoplasia syndrome type I. Relationship to HLA and carcinoid tumors.

Authors:  N R Farid; S Buehler; N A Russell; F B Maroun; P Allerdice; H S Smyth
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965

4.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

5.  Linkage analysis of multiple endocrine neoplasia type 1 with INT2 and other markers on chromosome 11.

Authors:  S J Bale; A E Bale; K Stewart; L Dachowski; O W McBride; T Glaser; J E Green; J J Mulvihill; M L Brandi; K Sakaguchi
Journal:  Genomics       Date:  1989-04       Impact factor: 5.736

6.  Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11.

Authors:  Y Nakamura; C Larsson; C Julier; C Byström; B Skogseid; S Wells; K Oberg; M Carlson; T Taggart; P O'Connell
Journal:  Am J Hum Genet       Date:  1989-05       Impact factor: 11.025

7.  Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage.

Authors:  N E Simpson; K K Kidd; P J Goodfellow; H McDermid; S Myers; J R Kidd; C E Jackson; A M Duncan; L A Farrer; K Brasch
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

8.  Variant multiple endocrine neoplasia I (MEN IBurin): further studies and non-linkage to HLA.

Authors:  J C Bear; R Briones-Urbina; J F Fahey; N R Farid
Journal:  Hum Hered       Date:  1985       Impact factor: 0.444

9.  Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.

Authors:  C Larsson; B Skogseid; K Oberg; Y Nakamura; M Nordenskjöld
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

10.  A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.

Authors:  R M Hofstra; R M Landsvater; I Ceccherini; R P Stulp; T Stelwagen; Y Luo; B Pasini; J W Höppener; H K van Amstel; G Romeo
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

View more
  13 in total

1.  A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus.

Authors:  S C Guru; S K Agarwal; P Manickam; S E Olufemi; J S Crabtree; J M Weisemann; M B Kester; Y S Kim; Y Wang; M R Emmert-Buck; L A Liotta; A M Spiegel; M S Boguski; B A Roe; F S Collins; S J Marx; L Burns; S C Chandrasekharappa
Journal:  Genome Res       Date:  1997-07       Impact factor: 9.043

2.  The epidemiology of prolactinomas.

Authors:  Antonio Ciccarelli; Adrian F Daly; Albert Beckers
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 3.  Familial pituitary tumor syndromes.

Authors:  Marianne S Elston; Kerrie L McDonald; Roderick J Clifton-Bligh; Bruce G Robinson
Journal:  Nat Rev Endocrinol       Date:  2009-06-30       Impact factor: 43.330

4.  Investigation of a cluster of pituitary adenomas in workers in the aluminum industry.

Authors:  M R Cullen; H Checkoway; B H Alexander
Journal:  Occup Environ Med       Date:  1996-11       Impact factor: 4.402

5.  Histologic and Molecular Profile of Pediatric Insulinomas: Evidence of a Paternal Parent-of-Origin Effect.

Authors:  Tricia R Bhatti; Karthik Ganapathy; Alison R Huppmann; Laura Conlin; Kara E Boodhansingh; Courtney MacMullen; Susan Becker; Linda M Ernst; N Scott Adzick; Eduardo D Ruchelli; Arupa Ganguly; Charles A Stanley
Journal:  J Clin Endocrinol Metab       Date:  2016-01-12       Impact factor: 5.958

Review 6.  Multiple endocrine neoplasia type 1Burin from Mauritius: a novel MEN1 mutation.

Authors:  C Kong; S Ellard; C Johnston; N R Farid
Journal:  J Endocrinol Invest       Date:  2001-11       Impact factor: 4.256

7.  Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect.

Authors:  H Brauch; T Kishida; D Glavac; F Chen; F Pausch; H Höfler; F Latif; M I Lerman; B Zbar; H P Neumann
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

8.  Improved carrier testing for multiple endocrine neoplasia, type 1, using new microsatellite-type DNA markers.

Authors:  S Kytölä; J Leisti; R Winqvist; P Salmela
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

9.  Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.

Authors:  S Giraud; C X Zhang; O Serova-Sinilnikova; V Wautot; J Salandre; N Buisson; C Waterlot; C Bauters; N Porchet; J P Aubert; P Emy; G Cadiot; B Delemer; O Chabre; P Niccoli; F Leprat; F Duron; B Emperauger; P Cougard; P Goudet; E Sarfati; J P Riou; S Guichard; M Rodier; A Meyrier; P Caron; M C Vantyghem; M Assayag; J L Peix; M Pugeat; V Rohmer; M Vallotton; G Lenoir; P Gaudray; C Proye; B Conte-Devolx; P Chanson; Y Y Shugart; D Goldgar; A Murat; A Calender
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

10.  The genetic ascertainment of multiple endocrine neoplasia type 1 syndrome by ancient DNA analysis.

Authors:  F Marini; S Carbonell Sala; A Falchetti; D Caramelli; M L Brandi
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.